Strides Arcolab

This page shows the latest Strides Arcolab news and features for those working in and with pharma, biotech and healthcare.

India turns down patent on Gilead's Sovaldi

Cipla, Cadila Healthcare, Hetero, Strides Arcolab, Ranbaxy, Sequent Scientific and Mylan) at a 7% royalty rate.

Latest news

Sovaldi deal for developing world ‘falls short’

Strides Arcolab - include some of the world's largest generic players, reports the Pharmalot blog.
Pfizer inks $360m deal to buy InnoPharma

Last year, generics giant Mylan made a big leap forward in the sector with a $1.6bn agreement to buy Strides Arcolab's sterile injectables unit Agila, while Becton Dickinson has
Hikma to retain injectables unit

Hikma said in March it decided to look into the future of the division after being sent unsolicited offers in the wake of Mylan's $1.6bn deal to acquire Strides ... Arcolab's injectables unit.
Injectables land-grab set to continue as Hikma reports offers

Hikma has said it is looking into the future of its injectable drugs unit after overtures from possible buyers, just days after Mylan agreed a $1.6bn deal to buy Strides ... Mylan said when it announced its deal for Strides Arcolab's Agila unit that it
Mylan agrees $1.6bn deal to buy Agila injectables unit

Consolidation continues apace in the generics sector, with Mylan agreeing a $1.6bn deal to acquire Strides Arcolab of India's sterile injectables business unit.

More from news
Approximately 2 fully matching, plus 12 partially matching documents found.

Latest Intelligence

Pharma deals in May 2015

360. Aspen/ Strides Arcolab. Divestment. Range of branded and generic drugs.
Deal Watch table for September 2014

200. Shasun / Strides Arcolab. Company acquisition. Shasun is an Indian API and generic company.
Pharma deals during September 2014

year. In India this month, Strides Arcolab has acquired another Indian generic and API supplier Shasun in an all stock deal worth $200m to add products to its portfolio.
The rise of chronic disease in BRIC markets

with Strides Arcolab to jointly manufacture and distribute generic cancer drugs in developing markets.
Pharma deals during February 2013

In the largest, it announced its planned acquisition of Strides Arcolab's subsidiary, Agila Specialities for a total of $1.85bn.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Editor – Medical Education Agency – Bucks: Salary TBC

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Senior Account Manager or AD - Medical Communications: Salary TBC

Senior Account Manager – Med Comms – Kent: Salary TBC

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Senior Programme Executive: Salary TBC

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Senior Account Manager / Account Director: Great salary and bebefits

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Scientific Director: Great salary and bebefits

Editorial Director – Medical Education – Oxford: Negotiable

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Medical Writer - (London, Brighton or Copenhagen): Competitive

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Senior Medical Writer: Great salary and benefits

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Senior Medical Writer: Great salary and bebefits

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Account Manager – Med Comms – London: Salary TBC

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Subscribe to our email news alerts

PMHub

Add my company

StratX

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...